A Phase 3, double blind, Randomised, Long-Term, Placebo Controlled, Multicentre study Evaluating the safety and efficacy of Obeticholic acid in subjects with Nonalcoholic Steatohepatitis (NASH). (REGENERATE)
1st April 2016 - ongoing
Status: In Recruitment
Specialism: Liver, Non-Alcoholic Fatty Liver Disease (NAFLD).
|Professor Guruprasad Aithal||Biography Professor Guruprasad P. Aithal is the Professor of Hepatology and the Head of the Division for the Nottingham Digestive Diseases Centre and Deputy Director of Nottingham Molecular Pathology Node. Professor Aithal is the GI & Liver Disorder…|
|Dr Waleed Fateen|
|Dr Stephen Ryder|